foundayo
Entity, reached from Hormuz.
- Evidence
- 31 documents · 17 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 6 Apr 2026, last seen 9 Oct 2026
- Measured
- 29% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- Medical Daily · 2026-10-03 · Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss (opens the source in a new tab)
- Fierce Pharma · 2026-10-01 · Lilly gives deeper glimpse at Foundayo's heart-helping odds in diabetes, obesity phase 3 (opens the source in a new tab)
- Clinical Trials Arena · 2026-09-30 · Lilly reports comparative data from ACHIEVE-3 and PIONEER PLUS studies (opens the source in a new tab)
- FDA Press Releases · 2026-04-06 · [APPROVAL] FDA Approves First New Molecular Entity Under National Priority Voucher Program (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with eli lilly (28 documents)seen together
- co-mentioned with glp-1 (26 documents)seen together
- co-mentioned with zepbound (16 documents)seen together
- co-mentioned with fda (16 documents)seen together
- co-mentioned with mounjaro (13 documents)seen together
- co-mentioned with novo nordisk (11 documents)seen together
- co-mentioned with glp-1s (8 documents)seen together